Drug Type ASO |
Synonyms- |
Target |
Action modulators |
Mechanism STXBP1 modulators(syntaxin binding protein 1 modulators) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhaseDiscovery |
First Approval Date- |
Regulation- |

| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Neurodevelopmental Disorders | Discovery | United States | 26 Feb 2024 | |
| STXBP1-related epileptic encephalopathy | Discovery | United States | 26 Feb 2024 |





